NASDAQ:OFIXOrthofix Medical Stock Price, Forecast & News

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OFIX shares have decreased by 0.2% and is now trading at $30.61. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical.

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Orthofix Medical.

Orthofix Medical Inc (NASDAQ:OFIX) issued its earnings results on Friday, May, 8th. The medical device company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The medical device company earned $104.82 million during the quarter, compared to analysts' expectations of $104.50 million. Orthofix Medical had a negative net margin of 0.81% and a positive return on equity of 7.46%. View Orthofix Medical's earnings history.

Orthofix Medical issued an update on its first quarter 2020 Pre-Market earnings guidance on Thursday, April, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $104-105 million, compared to the consensus revenue estimate of $106.54 million.

2 analysts have issued twelve-month price targets for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they expect Orthofix Medical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 60.1% from the stock's current price. View analysts' price targets for Orthofix Medical.

News coverage about OFIX stock has trended negative on Wednesday, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Orthofix Medical earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Orthofix Medical.

Orthofix Medical saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 321,700 shares, a decline of 9.4% from the June 15th total of 355,200 shares. Based on an average trading volume of 165,400 shares, the days-to-cover ratio is presently 1.9 days. Currently, 1.7% of the company's shares are short sold. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Becton Dickinson and (BDX), Stryker (SYK), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Insulet (PODD) and Steris (STE). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Exxon Mobil (XOM), Allergan (AGN), Biogen (BIIB), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Edwards Lifesciences (EW) and Intercept Pharmaceuticals (ICPT).

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Orthofix Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.25%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View institutional ownership trends for Orthofix Medical.

OFIX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. View insider buying and selling activity for Orthofix Medical.

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $30.61.

Orthofix Medical has a market capitalization of $587.77 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe.

The official website for Orthofix Medical is www.orthofix.com.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]